Hutchmed (China), controlled by tycoon Li Ka-shing, is selling stakes in its health subsidiary for around $608 million as the ...
Biopharmaceutical firm Hutchmed China Ltd., backed by billionaire Li Ka-shing, has agreed to sell stakes in a health unit for ...
Hutchmed, a biopharmaceutical company controlled by Hong Kong’s wealthiest person Li Ka-shing, is divesting a 45% stake in a ...
Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...
The Li Ka-shing Center for Biomedical and Health Sciences will make a huge contribution to the advancement of medical research. The facility houses computer scientists, biologists, physicists, ...
Biopharmaceutical firm Hutchmed China Ltd., backed by Hong Kong billionaire Li Ka-shing, saw its shares rally on Thursday ...
Shareholding disclosures revealed that from the 17th to the 20th of this month, the Li Ka Shing Foundation invested nearly ...
HUTCHMED (China), controlled by tycoon Li Ka-shing, is selling stakes in its health subsidiary for around US$608 million as ...
Jan 1 (Reuters) - Hutchmed (China)(0013.HK), opens new tab, controlled by tycoon Li Ka-shing, is selling stakes in its health subsidiary for around $608 million as the billionaire and his flagship ...